A Phase II study in adult patients with newly-diagnosed chronic myeloid leukaemia of initial intensified Glivec® therapy, and sequential combination therapy for non-responders, in order to assess response and survival (CML06)

Dataset includes Data for data for 103 patients with newly diagnosed CML Trial is a single arm treatment of Glivec for all patients, with monitoring of disease response Dataset includes demographic data, diagnostic, treatment data, outcome data本数据集包含103例新诊断慢性髓系白血病（Chronic Myeloid Leukemia, CML）患者的相关临床数据。本试验为单臂临床试验，所有入组患者均接受Glivec（格列卫）治疗，并同步监测其疾病应答情况。数据集涵盖人口统计学数据、诊断相关数据、治疗相关数据及结局数据。